Documents
Large vs. Small Molecules in Biopharmaceuticals
Biopharmaceuticals have emerged as the next-gen of therapeutic (large and small) molecules in the pharmaceutical industry. Dr. Chad Eichman, Biopharmaceutical Industry Manager, Phenomenex reviews the increase in pharmaceutical R&D efforts toward biologics products, and the shift seen within analytical companies towards novel solutions for biologics characterization.
Large vs. Small Molecules in Biopharmaceuticals
Biopharmaceuticals have emerged as the next-gen of therapeutic (large and small) molecules in the pharmaceutical industry. Dr. Chad Eichman, Biopharmaceutical Industry Manager, Phenomenex reviews the increase in pharmaceutical R&D efforts toward biologics products, and the shift seen within analytical companies towards novel solutions for biologics characterization.
Document Type:
Technical Notes
Brands:
Separation Modes:
Reversed Phase, Size Exclusion